Mononuclear leukocyte apoptosis and inflammatory markers in patients with chronic kidney disease

American Journal of Nephrology

Volumn 36, Issue 6, 2012, Pages 531-536

  Dounousi, Evangelia ^a   Koliousi, Elli ^a   Papagianni, Aikaterini ^b   Ioannou, Kyriakos ^d   Zikou, Xanthi ^a   Katopodis, Konstantinos ^a   Kelesidis, Apostolos ^d   Tsakiris, Dimitrios ^c   Siamopoulos, Kostas C ^a,e  

^a Department of Nephrology ^*  (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c Aristotle University of Thessaloniki   (Greece)

^d GENERAL HOSPITAL OF VERIA   (Greece)

^e UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Apoptosis; Chronic kidney disease; Inflammation

Indexed keywords

C REACTIVE PROTEIN; FAS ANTIGEN; FAS LIGAND; FIBRINOGEN; INTERLEUKIN 6; LIPOCORTIN 5; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FIBRINOGEN; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84870292150     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000345352     Document Type: Article

References (25)

1. Jaber BL, Cendoroglo M, Balakrishnan VS, Perianayagam MC, King AJ, Pereira BJ: Apoptosis of leukocytes: basic concepts and implications. Kidney Int 2001; 59(suppl 78): S197-S205. (Pubitemid 32144098)
2. Koliousi E, Vartholomatos G, Katopodis KP, Kolaitis N, Siamopoulos KC: Effect of the hemodialysis session on Bcl-2 expression in peripheral blood mononuclear cells in vivo. Blood Purif 2006; 24:542-547. (Pubitemid 46030097)
3. Majewska E, Baj Z, Sulowska Z, Rysz J, Lu-ciak M: Effects of uraemia and haemodialy-sis on neutrophil apoptosis and expression of apoptosis-related proteins. Nephrol Dial Transplant 2003; 18: 2582-2588. (Pubitemid 37483792)
4. Stenvinkel P, Ketteler M, Johnson RJ, Lind-holm B, Pecoits-Filho R, Riella M, Urger HO, Cederholm T, Girndt M: IL-10, IL-6, and TNF-a: Central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int 2005; 67:1216-1233. (Pubitemid 40463099)
5. Stenvinkel P, Carrero JJ, Axelsson J, Lind-holm B: Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008; 3:505-521.
6. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
7. TM; A new standard for fluorescence quantititation. White paper. Scan Jose, Bec-ton Dickinson Immunocytometry Systems, pl-16, part No 23-3496-00, 1997.
8. Vermes I, Haanen C, Steffen-Nakken H, Reu telingsperger C: A novel assay for apoptosis: flow cytometry detection of phoshati-dylserine expression on early apoptotic cells using fluorescein labeled annexin V J Immunol Methods 1995; 184: 39-51.
9. Cendoroglo M, Jaber BL, Balakrishnan VS, Perianayagam MC, King AJ, Pereira BJG: Neutrophil apoptosis and dysfunction in uremia. J Am Soc Nephrol 1999; 10:93-100. (Pubitemid 29034947)
10. Perianayagam MC, Murray SL, Balakrishnan VS, Guo D, King AJ, Pereira BJ, Jaber BL: Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney disease. J Lab Clin Med 2000; 136: 320-327.
11. Fernández-Fresnedo G, Ramos MA, Gon-zález-Pardo MC, de Francisco AL, López-Hoyos M, Arias M: B lymphopenia in uraemia is related to an accelerated in vitro apoptosis and dysfunction of Bcl-2. Nephrol Dial Transplant 2000; 15:502-510. (Pubitemid 30160657)
12. Blanco-Colio LM, Martín-Ventura JL, de Teresa E, Farsang C, Gaw A, Gensini G, Leiter LA, Langer A, Martineau P, Hérnandez G, Egido J: ACTFAST investigators. Increased soluble Fas plasma levels in subjects at high cardiovascular risk: atorvastatin on inflammatory markers (AIM) study, a substudy of ACTFAST. Arterioscler Thromb Vasc Biol 2007; 27: 168-174. (Pubitemid 46360395)
13. Troyanov S, Hébert M-J, Masse M, Vigneault N, Sirois I, Madore F: Soluble Fas: a novel predictor of atherosclerosis in dialysis patients. Am J Kidney Dis 2003; 41:1043-1051. (Pubitemid 36532139)
14. Schaub FJ, Han DK, Liles WC, Adams LD, Coats SA, Ramachandran RK, Seifert RA, Schwartz SM, Bowen-Pope DF: Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat Med 2000; 6: 790-796. (Pubitemid 30469428)
15. Shahid M, Francis J, Majid DSA: Tumor necrosis factor-a induces renal vasoconstriction as well as natriuresis in mice. Am J Physiol Renal Physiol 2008; 295:F1836-F1844.
16. Vaccaro F, Mule G, Cottone S, Giannitrapani L, Vadala A, Sparacino V Calabrese S, Pi-cone FP, Montalto G, Cerasola G: Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein. Arch Med Res 2007; 38: 534-538. (Pubitemid 46873808)
17. Witko-Sarsat V Friedlander M, Nguyen Khoa T, Capeillère-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drüeke T, Descamps-Latscha B: Advanced products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998; 161:2524-2532. (Pubitemid 28397070)
18. Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, Verger C, Dahmane D, de Groote l lD, Jungers P, Dayert J-M: Balance between IL-1ß, TNF-a and their specific inhibitors in chronic renal failure and maintenance dialysis. J Immunol 1995; 154:882-892.
19. Landray MJ, Wheeler DC, Lip GY, Newman DJ, Blann AD, McGlynn FJ, Ball S, Townend JN, Baigent C: Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: The Chronic Renal Impairment in Birmingham (CRIB) Study. Am J Kidney Dis 2004; 43: 244-253. (Pubitemid 38146322)
20. Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG: Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant 2007; 22:1087-1092. (Pubitemid 46523422)
21. Bash LD, Erlinger TP, Coresh J, Marsh-Man-zi J, Folsom AR, Astor BC: Inflammation, hemostasis, and the risk of kidney function decline in the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis 2009; 53: 596-605.
22. Fried L, Solomon C, Shlipak M, Bleyer AJ, Chaves P, Furberg C, Kuller L, Newman A: Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol 2004; 15: 3184-3191. (Pubitemid 39578851)
23. Bolton CH, Downs LG, Victory JG, Dwight JF, Tomson CR, Mackness MI, Pinkney JH: Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 2001; 16:1189-1197. (Pubitemid 32547374)
24. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM: Elevations of inflammatory and proco-agulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92. (Pubitemid 36070938)
25. Tsirpanlis G, Bagos P, Ioannou D, Bleta A, Marinou I, Lagouranis A, Chatzipanagiotou S, Nicolaou C: The variability and accurate assessment of microinflammation in hemodialysis patients. Nephrol Dial Transplant 2004; 19: 150-157. (Pubitemid 38072626)